CLINICAL_TRIALS
trial_result
· 2021-10-19
Clinical Trial Update: Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease [Phase 3]
Summary
Phase 3 clinical trial update evaluating efficacy and safety of osilodrostat in Cushing's disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Cushing's Disease | Phase 3 | Status: COMPLETED | Results posted: 2021-10-19